ABN 78 169 979 971 N O T I C E O F A N N U A L G E N E R A L M E E T I N G E X P L A N AT O R Y M E M O R A N D U M P R O X Y F O R M Date of Meeting Friday, 20 November 2026 Time of Meeting 9:30 am (AWST) Place of Meeting Harry Perkins Institute QEII Medical Centre QQ Block 6 Verdun Street,...
Notice of Annual General Meeting/Proxy Form
Filed with ASX · · 28 pages · English
Summary by 6ix AI
This filing is a notice for the Annual General Meeting of Proteomics International Laboratories Ltd., detailing the meeting's agenda and resolutions to be voted on by shareholders. The meeting is scheduled to take place at the Harry Perkins Institute, and it includes various resolutions such as the adoption of the remuneration report and the re-election of directors. Shareholders are encouraged to participate by voting in person or by proxy, with specific instructions provided for both methods of voting.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Proteomics International Laboratories Ltd. on 6ix
Earlier from Proteomics International Laboratories
- Proteomics International receives $2.0m in R&D tax incentive
- Ignite Investment Summit Presentation
- PromarkerEndo Validation and Refinement Complete
- Notice of AGM Date
- Investor Presentation
Later from Proteomics International Laboratories
- National Rollout of PromarkerD and PromarkerEso
- Quarterly Activities/Appendix 4C Cash Flow Report
- Proteomics International Launches Share Purchase Plan
- Proposed issue of securities - PIQ
- Share Purchase Plan Cleansing Notice
